Vistagen Therapeutics Inc.

NASDAQ: VTGN
Share price (3/14/25): $2.70
Market cap (3/14/25): $77.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 Q3

ended 09/30/24 Q2

ended 06/30/24 Q1

ended 03/31/24 FY 2024

ended 12/31/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Great Point Partners LLC

Stempoint Capital LP

Biotechnology Value Fund L P

Prince Joshua S.

Anderson Cynthia Lynn

News Filter

To Participate in Stifel 2025 Virtual CNS Forum

Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update

Receives U.S. Patent for AV-101 to Treat Neuropathic Pain

Announces Positive Results From Exploratory Phase 2A Study of PH284 in Cancer Cachexia

Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC